Preclinical Diagnosis of DAT by Brain Mapping

About the Research Project
Program
Award Type
Standard
Award Amount
$197,141
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000022
Summary
The disease processes causing dementia of the Alzheimer’s type (DAT) are thought to exist in the brain for several years before clinical symptoms appear. Brain-scanning techniques are being applied with increasing accuracy to identify early changes in brain structure that might precede a clinical diagnosis of Alzheimer’s disease (AD). Dr. Csernansky has used these methods to study subjects with very early AD symptoms. He has already detected changes in the shape of the brain and a shrinkage of the hippocampus, one of the areas most affected by AD. He is now performing tests to determine whether these methods can predict the course of the disease. High-resolution magnetic resonance imaging (MRI) scans and brain mapping will be performed on healthy elderly subjects between the ages of 55 and 90. The subjects are being followed for several years to determine the onset and degree of dementia symptoms. Also, because a mutation in the ApoE gene is a risk factor for developing AD, the predictive power of the brain scans will be assessed with and without testing for the ApoE mutation. If Dr. Csernansky’s hypothesis is correct, the diagnosis of AD could be made earlier in the disease process, which could lead to earlier and more successful treatments for AD.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD